ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOBAYASHI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Accounts payable

KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967)

Market cap
¥457B
P/E ratio
43.5x
Kobayashi Pharmaceutical makes healthcare products and consumer goods like deodorizers and oral care items, serving domestic and international markets through 40 subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndAccounts payable (Million JPY)YoY (%)
Dec 31, 20258,458+2.35%
Dec 31, 20248,264-5.50%
Dec 31, 20238,745-3.38%
Dec 31, 20229,051-2.60%
Dec 31, 20219,293+22.96%
Dec 31, 20207,558-8.68%
Dec 31, 20198,276-4.94%
Dec 31, 20188,706+5.16%
Dec 31, 20178,279+1.35%
Dec 31, 20168,169+14.40%
Mar 31, 20167,141-30.26%
Mar 31, 201510,239

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat